CLINUVEL Confirms AGM Date
03 October 2018 CLINUVEL PHARMACEUTICALS LTD (ASX: CUV; XETRA-DAX: UR9; NASDAQ INTERNATIONAL...
Read More
CLINUVEL Initiates Variegate Porphyria Proof of Concept Study
01 October 2018 CLINUVEL PHARMACEUTICALS LTD today announced that it has reached...
Read More
Nasdaq International Designation Virtual Investor Conference Presentation
20 September 2018 CLINUVEL PHARMACEUTICALS LTD (ASX: CUV; XETRA-DAX: UR9; NASDAQ INTERNATIONAL...
Read More
Appendix 3B
11 September 2018 New issue announcement, application for quotation of additional securities...
Read More
Investor Presentation NewsMakers Conference
10 September 2018 CLINUVEL PHARMACEUTICALS LTD (ASX: CUV; XETRA-DAX: UR9; NASDAQ INTERNATIONAL...
Read More
US FDA Update
05 September 2018 CLINUVEL PHARMACEUTICALS LTD (ASX: CUV; XETRA-DAX: UR9; NASDAQ INTERNATIONAL...
Read More
Change in substantial holding
04 September 2018 Enclosed is a notice of change of interests of...
Read More
CLINUVEL declares first time dividend
29 August 2018 CLINUVEL PHARMACEUTICALS LTD (ASX: CUV; XETRA-DAX: UR9; NASDAQ INTERNATIONAL...
Read More
Appendix 4E and Preliminary Financial Report
29 August 2018 The Directors of the Board present their report on...
Read More
CLINUVEL Investor Summary
21 August 2018 Increasing interest has been seen in the interaction between...
Read More
Appendix 4C
30 July 2018 CLINUVEL PHARMACEUTICALS LTD (ASX: CUV; XETRA-DAX: UR9; NASDAQ INTERNATIONAL...
Read More
CLINUVEL Newsletter - July 2018
27 July 2018 On 25 June 2018 CLINUVEL announced its New Drug...
Read More
Change in substantial holding
17 July 2018 Enclosed is a notice of a change of interest...
Read More
Change in Director's Interest Notice
6 July 2018 Enclosed is a change in director’s interest notice. Download...
Read More